Cairo, Egypt – Grinta, a leading healthcare and pharmaceutical solutions company, has announced its acquisition of Citi Clinic, a well-established primary healthcare service chain in Egypt. This strategic move is accompanied by an undisclosed amount of investment secured through a funding round led by Beltone Venture Capital and Raed Ventures, marking a significant milestone in Grinta’s expansion journey.
The acquisition grants Grinta access to over 150,000 patients, strengthening its foothold in the healthcare sector and reinforcing its commitment to providing accessible and high-quality care.
Mohamed Azab, Co-founder and CEO of Grinta, highlighted the transformative nature of the acquisition, stating:
“The acquisition of Citi Clinic is a transformative step for Grinta. It not only allows us to enter the care market but also enables us to integrate offline and online services, reshaping how healthcare is accessed and delivered. We look forward to the opportunities ahead as we expand our reach and impact.”
The move aligns with a broader global trend where B2B pharmaceutical distributors are expanding into B2C operations. Industry giants like McKesson and Walgreens have successfully adopted similar models, leveraging their supply chain expertise to deliver comprehensive healthcare services directly to consumers. Following this approach, Grinta aims to expand its physical and digital healthcare offerings across Egypt and East Africa.
As part of its strategic shift, Grinta has exited its B2B retail pharmaceutical distribution business in Egypt to focus exclusively on the care sector.
Ali Mokhtar, Managing Director of Beltone Venture Capital, expressed strong support for Grinta’s new direction:
“We are excited to support Grinta as they reshape the healthcare and pharmaceutical space. Their shift into primary care and retail reflects their ability to adapt to market demands, positioning them for long-term success in the region.”
Wael Nafee, General Partner at Raed Ventures, echoed this sentiment, stating:
“We’re pleased to back Grinta and its management team once again. Their innovative approach continues to impress us, and with this acquisition, we’re looking forward to their ambitious plans to improve healthcare access and delivery across emerging markets.”
Beyond Egypt, Grinta is also extending its footprint in East Africa, particularly in Tanzania. The company is exporting pharmaceutical products and forging partnerships with Egyptian manufacturers. In addition, Grinta is developing a pharmacy chain in Tanzania through a buy-and-build strategy, further strengthening its presence in the region.
Grinta’s entry into the primary care market and its patient-centric approach reflect its broader mission to transform healthcare across multiple regions. By integrating both physical and digital solutions, the company aims to enhance healthcare access and quality for communities across Egypt and East Africa.
